- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2016
- Public Summary Document (PSD) July 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2016 PBAC Meeting - Word
Ipilimumab – July 2016
Ipilimumab: 50 mg/10 mL injection, 10 mL, 200 mg/40 mL injection, 40 mL, Yervoy®
Last updated
28 October 2016